Pituitary somatostatin receptor signaling
- PMID: 20149677
- PMCID: PMC2834886
- DOI: 10.1016/j.tem.2009.12.003
Pituitary somatostatin receptor signaling
Abstract
Somatotropin-release inhibitory factor (SRIF) is a major regulator of pituitary function, mostly inhibiting hormone secretion and to a lesser extent pituitary cell growth. Five SRIF receptor subtypes (SSTR1-5) are ubiquitously expressed G-protein coupled receptors. In the pituitary, SSTR1, 2, 3 and 5 are expressed, with SSTR2 and SSTR5 predominating. As new SRIF analogs have recently been introduced for treatment of pituitary disease, we evaluate the current knowledge of cell-specific pituitary SRIF receptor signaling and highlight areas of future research for comprehensive understanding of these mechanisms. Elucidating pituitary SRIF receptor signaling enables understanding of pituitary hormone secretion and cell growth, and also encourages future therapeutic development for pituitary disorders.
Copyright 2009 Elsevier Ltd. All rights reserved.
Similar articles
-
Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation.J Clin Invest. 1997 Feb 15;99(4):789-98. doi: 10.1172/JCI119225. J Clin Invest. 1997. PMID: 9045884 Free PMC article.
-
Somatostatin receptor subtype gene expression in pituitary adenomas.J Clin Endocrinol Metab. 1995 Apr;80(4):1386-92. doi: 10.1210/jcem.80.4.7714115. J Clin Endocrinol Metab. 1995. PMID: 7714115
-
Evidence for differential effects of selective somatostatin receptor subtype agonists on alpha-subunit and chromogranin a secretion and on cell viability in human nonfunctioning pituitary adenomas in vitro.J Clin Endocrinol Metab. 2004 Oct;89(10):5181-8. doi: 10.1210/jc.2003-031954. J Clin Endocrinol Metab. 2004. PMID: 15472224
-
Somatostatin receptors in pituitary and development of somatostatin receptor subtype-selective analogs.Endocrine. 2003 Apr;20(3):265-9. doi: 10.1385/ENDO:20:3:265. Endocrine. 2003. PMID: 12721506 Review.
-
Somatostatin system: molecular mechanisms regulating anterior pituitary hormones.J Mol Endocrinol. 2014 Aug;53(1):R1-19. doi: 10.1530/JME-14-0034. Epub 2014 Apr 29. J Mol Endocrinol. 2014. PMID: 24780840 Review.
Cited by
-
Epithelial-Mesenchymal Transition in the Resistance to Somatostatin Receptor Ligands in Acromegaly.Front Endocrinol (Lausanne). 2021 Mar 15;12:646210. doi: 10.3389/fendo.2021.646210. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33790868 Free PMC article.
-
Idiopathic adult growth hormone deficiency.J Clin Endocrinol Metab. 2013 Jun;98(6):2187-97. doi: 10.1210/jc.2012-4012. Epub 2013 Mar 28. J Clin Endocrinol Metab. 2013. PMID: 23539718 Free PMC article. Review.
-
Whole-genome resequencing reveals recent signatures of selection in five populations of largemouth bass ( Micropterus salmoides).Zool Res. 2023 Jan 18;44(1):78-89. doi: 10.24272/j.issn.2095-8137.2022.274. Zool Res. 2023. PMID: 36349358 Free PMC article.
-
Cell specific interaction of pasireotide: review of preclinical studies in somatotroph and corticotroph pituitary cells.Pituitary. 2019 Feb;22(1):89-99. doi: 10.1007/s11102-018-0926-y. Pituitary. 2019. PMID: 30483918 Review.
-
Dimerization of GPCRs: Novel insight into the role of FLNA and SSAs regulating SST2 and SST5 homo- and hetero-dimer formation.Front Endocrinol (Lausanne). 2022 Aug 5;13:892668. doi: 10.3389/fendo.2022.892668. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35992099 Free PMC article.
References
-
- Patel YC. Somatostatin and its receptor family. Front Neuroendocrinol. 1999;20(3):157–198. - PubMed
-
- Reichlin S. Somatostatin. N Engl J Med. 1983;309(24):1495–1501. - PubMed
-
- Weckbecker G, et al. Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Nat Rev Drug Discov. 2003;2(12):999–1017. - PubMed
-
- Patel YC, Srikant CB. Somatostatin mediation of adenohypophysial secretion. Annu Rev Physiol. 1986;48:551–567. - PubMed
-
- Mouhieddine OE, et al. Growth hormone (GH)-releasing hormone tonically inhibits in vitro endogenous somatostatin in human GH-secreting tumors. J Clin Endocrinol Metab. 1995;80(5):1691–1695. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials